Renaissance Technologies - NEUROSENSE THERAPEUTICS LTD ownership

NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240108. A total of 6 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NEUROSENSE THERAPEUTICS LTD
ValueSharesWeighting
Q4 2022$22
-100.0%
18,433
-66.1%
0.00%
Q3 2022$97,00054,3000.00%
Other shareholders
NEUROSENSE THERAPEUTICS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Vanguard Personalized Indexing Management, LLC 39,634$134,0000.01%
CLEAR STREET LLC 7,157$24,0000.00%
Tower Research Capital LLC (TRC) 9,794$33,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 20,259$68,0000.00%
CITIGROUP INC 49,744$168,0000.00%
JANE STREET GROUP, LLC 77,249$261,0000.00%
UBS Group AG 13,428$45,0000.00%
View complete list of NEUROSENSE THERAPEUTICS LTD shareholders